A new study published in Food Science & Nutrition sets out a validated framework for measuring the molecular weight distribution of fish-derived collagen peptides inside finished beverages, where vitamins, plant extracts and organic acids can distort the analytical signal.

Molecular weight is the whole game in this category. Peptide size governs absorption and the bioactivity behind marketed skin claims, and fractions below 1 kilodalton are generally considered the most bioavailable, yet existing national and industry standards for measuring it were written for simple peptide powders rather than multi-ingredient drinks.

Three methods, one column

Researchers in China compared three mainstream gel permeation chromatography methods drawn from Chinese national and enterprise standards, labeled A, B and C, each using a different acetonitrile-water-trifluoroacetic acid mobile phase. All three ran on the same size-exclusion column with UV detection at 220 nanometers, calibrated with standards from cytochrome C at 12,384 daltons down to glycylglycylglycine at 189 daltons, and were tested on a pure peptide powder plus two commercial beverages made from the same raw material batches.

The curve was never straight

The first finding is the kind of detail that quietly invalidates a lot of label data. The relationship between log molecular weight and retention time is sigmoidal, not linear, and linear fits returned R-squared values of 0.9898 to 0.9925 while leaving U-shaped residual patterns that signal systematic bias. Cubic polynomial fitting pushed R-squared to between 0.9970 and 0.9999, with Method B reaching 0.9999 and residuals within plus or minus 0.01.

The 20.5-minute fix

The practical breakthrough is simpler. Vitamin C and EGCG both eluted after the 20.5-minute mark, masquerading as peptides smaller than 189 daltons and inflating that apparent fraction to as much as 20 percent of the total in the beverages. Excluding peaks after 20.5 minutes removed the interference, after which powder and beverage profiles overlapped with all relative deviations below 10 percent and fingerprint similarity coefficients above 0.99.

Limitations

Everything ran on a single HPLC platform, so cross-instrument validation has not been done, and the exclusion rule has been tested in only two beverage matrices. The column also resolves poorly below 500 daltons, and the authors recommend LC-MS/MS or dedicated small-molecule columns for that range.

Bottom line

The authors argue that if the industry adopts cubic fitting as a shared convention, results from different labs become directly comparable, with inter-method variation below 5 percent in the sub-1 kDa region. What is still missing is the link between a precise peptide spectrum and any clinical endpoint, which the authors flag as future work.